Endometriosis is characterized as the ectopic presence of endometrium in various locations within the abdominal cavity, such as the fallopian tube, Pouch of Douglas, ovaries, outside of ovaries, and more. The inner lining of uterus, endometrium, is a dynamic tissue that experiences morphological and functional changes, cyclically. The proliferation of endometrial cells during menstruation is influenced by increasing circulating estrogen levels. Adult progenitor stem cells are likely responsible for this remarkable regenerative capacity and hence, enhanced capacity to generate endometriosis. This chronic estrogen-dependent disease is characterized by the ectopic endometrial implant. The incidence of the disorder is between 6% and 10% of reproductive-aged women, and 35%–50% of women with pelvic pain and infertility. Currently, preferred diagnosis is through laparoscopic inspection by transvaginal ultrasound, MRI, and sensors. Diagnosis with transvaginal ultrasound proceeds to have 92.7% sensitivity and 97% specificity in detecting endometriotic lesions. On average, MRI diagnosis of DIE consists of 74% sensitivity and 95% specificity. Lastly, chemical sensors have 91.7% sensitivity and 90.0% specificity in detecting endometriosis. The standard of care includes personalizing the treatment plan based on the individual’s set of symptoms and severity. Advances in biomedical engineering have aided professionals to personalize the course of treatments accordingly as well as to increase their standard of living through various therapies for managing pain.